INS and gestational diabetes: This view is similar to that of a study in Poland, in which Sokup [32] suggested that GDM women with HOMA > 1.29 should be treated with improved tissue sensitivity to insulin, while GDM women with HOMA > 2.89 should be treated with metformin combined with insulin.